Glomulin, FKBP associated protein pseudogene (No widely recognized canonical abbreviation; sometimes referred to as "GLMN pseudogene" (GLMN-P).)

The glomulin, FKBP associated protein pseudogene (ENSG00000225906) is a genomic element classified as a pseudogene—an inactive genetic copy resembling the functional GLMN gene. Unlike the parental glomulin protein, which is essential for vascular development and whose mutations cause glomuvenous malformations[5][7], the pseudogene does not code for a protein and is generally considered nonfunctional, though some pseudogenes can have regulatory functions at the RNA level. It is not a druggable target, does not interact with drugs, nor does it play a direct mechanistic role in disease. Research into pseudogenes suggests some may be aberrantly expressed or modulate disease processes by influencing gene expression networks, but the GLMN pseudogene itself is not a recognized therapeutic or diagnostic biomolecule[3][4][6]. Key point: This entry refers to a noncoding pseudogene and should not be treated as a classical molecular target in therapeutic contexts.

Other names

GLMN pseudogeneGlomulin pseudogeneENSG00000225906

None. Not a protein-coding target, so no drug mechanism of action applies